Pharvaris N.V.

PHVS

As of the close on Sep 25, 2026

Price

$32.02

Market cap

—

Figures are per ordinary share in the filer's currency; the US price is per depositary share

P/E (diluted TTM)

—

The last four quarters are not all on file

EPS (TTM)

—

The last four quarters are not all on file

Dividend yield

—

Figures are per ordinary share in the filer's currency; the US price is per depositary share

Figures shown here come from public SEC filings. Dates beside each section show the available history.

How Pharvaris N.V. Makes Money

No flow chart is shown because the available revenue and expense lines do not reconcile exactly. The reported financial history below remains available.

Financial Summary

Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.

Loading financial history…

SEC filings supply these figures; updates after the dates shown are not included. This page includes 6 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 29, 2026.

Ownership

Who holds the shares, as reported in SEC ownership filings.

Purchases & sales (open market or private)

		Security	Code		Price	Filing
2026-06-29	Schikan Johannes Gerardus Christiaan Petrus · Director	Common Stock	S — Open market or private sale	−2,400	35.10	SEC filing
2026-06-26	Lu Peng · Chief Medical Officer	Common Stock	S — Open market or private sale	−14,700	34.00	SEC filing
2026-06-25	Lesage Anne · Chief Early Development	Common Stock	S — Open market or private sale	−2,300	35.12	SEC filing
2026-06-25	Lu Peng · Chief Medical Officer	Common Stock	S — Open market or private sale	−3,400	35.09	SEC filing
2026-06-25	Lesage Anne · Chief Early Development	Common Stock	S — Open market or private sale	−2,300	35.12	SEC filing
2026-06-25	Lu Peng · Chief Medical Officer	Common Stock	S — Open market or private sale	−11,600	34.45	SEC filing
2026-06-18	Lu Peng · Chief Medical Officer	Common Stock	S — Open market or private sale	−300	34.00	SEC filing
2026-06-15	Modig Berndt · Chief Executive Officer	Common Stock	S — Open market or private sale	−100	31.46	SEC filing

Showing 8 of 10 rows

Grants, exercises, tax & gifts

		Security	Code		Filing
2026-06-26	Lu Peng · Chief Medical Officer	Common Stock	M — Exercise or conversion of derivative security	+14,700	SEC filing
2026-06-26	Lu Peng · Chief Medical Officer	Stock Option (Right to Buy)	M — Exercise or conversion of derivative security	−14,700	SEC filing
2026-06-25	Lu Peng · Chief Medical Officer	Common Stock	M — Exercise or conversion of derivative security	+15,000	SEC filing
2026-06-25	Lu Peng · Chief Medical Officer	Stock Option (Right to Buy)	M — Exercise or conversion of derivative security	−15,000	SEC filing
2026-06-25	Lesage Anne · Chief Early Development	Stock Option (Right to Buy)	M — Exercise or conversion of derivative security	−900	SEC filing
2026-06-25	Lesage Anne · Chief Early Development	Common Stock	M — Exercise or conversion of derivative security	+1,400	SEC filing
2026-06-25	Lesage Anne · Chief Early Development	Common Stock	M — Exercise or conversion of derivative security	+900	SEC filing
2026-06-25	Lesage Anne · Chief Early Development	Stock Option (Right to Buy)	M — Exercise or conversion of derivative security	−1,400	SEC filing

Showing 8 of 18 rows

These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.